HIGH GRADE OVARIAN CANCER
Clinical trials for HIGH GRADE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH GRADE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo trial pulled before it even started
Disease control TerminatedThis study was designed to test the safety and effectiveness of two drugs, bemarituzumab and bevacizumab, given together to people with advanced gynecologic cancers (endometrial, ovarian, or cervical) that have a specific protein called FGFR2b. The trial was withdrawn before enro…
Matched conditions: HIGH GRADE OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for ovarian cancer: targeted combo shows promise in recurrent cases
Disease control OngoingThis study tests a two-step treatment for a type of ovarian cancer that has come back after initial chemotherapy. First, patients receive a standard chemo drug (carboplatin) plus a targeted drug (mirvetuximab) that homes in on a protein called FRα found on cancer cells. Then, the…
Matched conditions: HIGH GRADE OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC